ClinicalTrialsFinder

Diffuse Large B Cell Lymphoma Clinical Trials in Buenos Aires, Buenos Aires F.D.

1 recruitingBuenos Aires, Buenos Aires F.D., Argentina

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

Diffuse Large B Cell Lymphoma
Merck Sharp & Dohme LLC1,046 enrolled246 locationsNCT06717347